53793-56-9

Usage

Uses

Used in Industrial Applications:
2,6-bis(aminomethyl)pyridinetetraacetate is used as a complexing agent for metal ions to facilitate metal ion sequestration and separation processes. Its ability to form stable complexes with a wide range of metal ions makes it suitable for use in various industrial processes, including water treatment, metal recovery, and purification of metal-containing solutions.
Used in Pharmaceutical Applications:
2,6-bis(aminomethyl)pyridinetetraacetate is used as a chelating agent in the development of pharmaceuticals, particularly for the treatment of metal poisoning and heavy metal overload. Its high affinity for metal ions allows for the safe and effective removal of toxic metals from the body, providing a potential therapeutic option for conditions caused by metal toxicity.
Used in Catalysis:
2,6-bis(aminomethyl)pyridinetetraacetate is employed as a ligand in homogeneous catalysis, where it can coordinate with metal catalysts to enhance their activity and selectivity. Its ability to form stable complexes with metal ions makes it a promising candidate for the development of new catalytic systems in organic synthesis and other chemical reactions.
Used in Medical Imaging:
2,6-bis(aminomethyl)pyridinetetraacetate is used as a chelating agent in the development of contrast agents for medical imaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT). Its ability to form stable complexes with metal ions allows for the creation of contrast agents with enhanced imaging properties, improving the diagnostic capabilities of these imaging modalities.

Upstream product

• 7703-74-4 2,6-bis-(bromomethyl)pyridine 
• 1109196-83-9 C₂₃H₃₅N₃O₈ 
• 144367-62-4 tetra(tert-butyl) 2,2',2'',2'''-<(pyridine-2,6-diyl)bis(methylenenitrilo)>tetrakis(acetate) 
• 89561-18-2 2,6-Pyridinbis(methylamin)-N,N,N',N'-tetraessigsaeure-tetramethylester 

Relevant academic research and scientific papers

Pyridine-based lanthanide complexes: Towards bimodal agents operating as near infrared luminescent and MRI reporters

We report two prototype Ln3+ complexes that address requirements for both MRI and luminescence imaging and we demonstrate that the presence of two H2O molecules bound to the Ln3+, beneficial for MRI applications of the Gd3+ analogue, is not a major limitation for the development of NIR luminescent agents. The Royal Society of Chemistry 2008.

New Heteroaromatic Complexing Agents and Luminescence of Their Europium(III) and Terbium(III) Chelates

Twelve heteroaromatic complexing agents 9a-l were synthesized with the purpose to develop suitable labels for time-resolved luminescence-based bioaffinity assays.The relative luminescence yields, excitation maxima, and emission decay constants of their europium(III) and terbium(III) chelates were determined.According to these results, 2,2',2'',2'''-tetrakis(acetic acid) (9e) and 2,2',2'',2'''-tetrakis(acetic acid) (9l) are the most promising agents.

Acidic Complexones Bearing Donor-enhancing Pyridine Anchour Groups

The synthesis, complex stability and -selectivity for alkaline earth metal ions 2,6-pyridinebis(methylamine)-N,N,N',N'-tetraacetic acids (3a) and their donor-enforced analogues 3b,c are described.The acid dissociation constants and the stability constants of the metal complexes have been measured potentiometrically at 25 deg C in water of constant ionic strength (μ = 0.1).The stability order is Ca > Mg > Sr > Ba which is analogous to the selectivity of EDTA and comparable aliphatic complexones.The magnitudes of the stability constants of 3a are comparable to those of EDTA, while the donor-enforced analogues 3b,c form less stable complexes with alkaline earth metal ions.